Monika M Kutyna

10PUBLICATIONS
55CO-AUTHORS
Medical infection agents (incl. prions)Medical virologyMolecular targetsChemical and thermal processes in energy and combustionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 01, 2026
Infection risk in myelodysplastic syndromes is dynamic and immune driven.

|Mar 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

|Feb 25, 2025
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm.

Nadia Gharaee, Joanna Wegrzyn-Woltosz, Jihong Jiang

|Oct 18, 2024
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.

Deepak Singhal, Monika M Kutyna, Christopher N Hahn

|Nov 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Daniel Thomas, Manhong Wu, Yusuke Nakauchi

|Aug 29, 2022
A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure.

Monika M Kutyna, Chung Hoow Kok, Yoon Lim

Pageof 2

Frequent Collaborators

6 joint publications

Christopher N Hahn

6 joint publications

Devendra K Hiwase

5 joint publications

Chung Hoow Kok

4 joint publications

Anna L Brown